Gavelli, F.; Giolitti, F.M.; Vidali, M.; Montersino, M.; Bertoli, M.; Molinari, L.; Baldrighi, M.; Beltrame, M.; Sainaghi, P.P.; Bellan, M.;
et al. Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 28-Day and 90-Day Mortality in Emergency Department Patients with Chest Pain, Dyspnoea, or Abdominal Pain. Diagnostics 2025, 15, 2851.
https://doi.org/10.3390/diagnostics15222851
AMA Style
Gavelli F, Giolitti FM, Vidali M, Montersino M, Bertoli M, Molinari L, Baldrighi M, Beltrame M, Sainaghi PP, Bellan M,
et al. Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 28-Day and 90-Day Mortality in Emergency Department Patients with Chest Pain, Dyspnoea, or Abdominal Pain. Diagnostics. 2025; 15(22):2851.
https://doi.org/10.3390/diagnostics15222851
Chicago/Turabian Style
Gavelli, Francesco, Francesca Maria Giolitti, Matteo Vidali, Marta Montersino, Matteo Bertoli, Luca Molinari, Marco Baldrighi, Michela Beltrame, Pier Paolo Sainaghi, Mattia Bellan,
and et al. 2025. "Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 28-Day and 90-Day Mortality in Emergency Department Patients with Chest Pain, Dyspnoea, or Abdominal Pain" Diagnostics 15, no. 22: 2851.
https://doi.org/10.3390/diagnostics15222851
APA Style
Gavelli, F., Giolitti, F. M., Vidali, M., Montersino, M., Bertoli, M., Molinari, L., Baldrighi, M., Beltrame, M., Sainaghi, P. P., Bellan, M., Patrucco, F., Avanzi, G. C., & Castello, L. M.
(2025). Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 28-Day and 90-Day Mortality in Emergency Department Patients with Chest Pain, Dyspnoea, or Abdominal Pain. Diagnostics, 15(22), 2851.
https://doi.org/10.3390/diagnostics15222851
